Compounds > glimepiride

glimepiride and lc15-0444

glimepiride has been researched along with lc15-0444 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Bae, KS; Bang, K; Choi, HY; Han, S; Kim, MJ; Kim, YH; Lee, SH; Lim, HS1
Cho, JH; Hur, GC; Jang, YH; Jung, CH; Kim, JH; Kim, SH; Lee, BW; Lee, SH; Lee, WJ; Park, CY; Park, SE; Suh, S1
Ahn, J; Florez, JC; Lim, S; Nauck, MA; Sohn, M1
Chung, SM; Hong, JH; Hwang, IC; Lim, S; Moon, JS1

Trials

4 trial(s) available for glimepiride and lc15-0444

ArticleYear
Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers.
    Drugs in R&D, 2014, Volume: 14, Issue:3

    Topics: Administration, Oral; Adult; Area Under Curve; Asian People; Chromatography, Liquid; Cross-Over Studies; Drug Interactions; Humans; Hypoglycemic Agents; Male; Piperidones; Pyrimidines; Republic of Korea; Sulfonylurea Compounds; Tandem Mass Spectrometry; Young Adult

2014
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:6

    Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidones; Pyrimidines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Young Adult

2017
Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study.
    Nutrients, 2023, Jan-03, Volume: 15, Issue:1

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gastrointestinal Microbiome; Glucose; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Intestines; Metformin; Middle Aged; Obesity; Treatment Outcome; Weight Gain

2023
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study.
    Diabetes, obesity & metabolism, 2023, Volume: 25, Issue:8

    Topics: Aged; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidones; Prospective Studies; Pyrimidines; Sulfonylurea Compounds

2023